FDA DEVICE FACTS
ZENITH ALPHA THORACIC ENDOVASCULAR GRAFT
Cook Medical Incorporated
Verified FDA Record identity for medical-device development research. This overview uses only fields stated in the FDA Record and is not a Device Description.医療機器開発の調査用に、確認済みの FDA Record の識別情報を示しています。この概要は FDA Record に記載された項目だけによるもので、機器説明ではありません。
Indications for use
The Zenith Alpha™ Thoracic Endovascular Graft is indicated for the endovascular treatment of patients with isolated lesions of the descending thoracic aorta (not including dissections) having vascular anatomy suitable for endovascular repair, including:
• Iliac/femoral anatomy that is suitable for access with the required introduction systems,
• Nonaneurysmal aortic segments (fixation sites) proximal and distal to the thoracic lesion:
• with a length of at least 20 mm, and
Zenith® AlphaTM Thoracic Endovascular Graft
• with a diameter measured outer wall to outer wall of no greater than 42 mm and no less than 15 mm.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。